Juggernaut entity buys WRAP shares, gets warrants
Juggernaut Management, LLC, an entity associated with WRAP director John D. Shulman, acquired 250,000 shares of common stock at $2.00 per share and 250,000 warrants with a $2.30 exercise price in a private placement on February 2, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Juggernaut Management, LLC, an entity associated with WRAP director John D. Shulman, acquired 250,000 shares of common stock at $2.00 per share and 250,000 warrants with a $2.30 exercise price in a private placement on February 2, 2026.
The warrants can be exercised into 250,000 WRAP common shares and their exercise price is adjustable if the company issues stock or convertible securities below $2.30. Following these transactions, Shulman also directly owned 79,394 WRAP common shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Warrants | 250,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 250,000 | $2.00 | $500K |
| holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. Reflects shares of the Issuer's common stock, par value $0.0001 per share (the "common Stock"), purchased by the Reporting Person from the Issuer in a private placement pursuant to that certain Securities Purchase Agreement, dated as of February 2, 2026, by and among the Issuer and the investors signatory thereto (the "Purchase Agreement").
- F2. The reported securities are directly owned by Juggernaut Management, LLC ("Juggernaut") and may be deemed to be beneficially owned by the Reporting Person as Manager of Juggernaut. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F3. The warrants (the "PIPE Warrants") were purchased by the Reporting Person from the Issuer in a private placement pursuant to the Purchase Agreement. The exercise price of the PIPE Warrants is subject to adjustment in the event of any issuances of Common Stock of the Issuer or securities convertible, exercisable or exchangeable for Common Stock, at a price below $2.30.
AI-generated analysis. How Rhea-AI works. Not financial advice.